Prognostic factors for regorafenib treatment in patients with refractory metastatic colorectal cancer: A real-life retrospective multi-center study

por Aydin, Sabin Goktas, Kavak, Engin Eren, Topcu, Atakan, Bayramgil, Ayberk, Akgul, Fahri, Kahraman, Seda, Aykan, Musa Baris, Altıntas, Yunus Emre, Helvaci, Kaan, Urun, Yuksel, Bilici, Ahmet, Seker, Mesut, Nahit Sendur, Mehmet Ali, Olmez, Omer Fatih, Acikgoz, Ozgur, Cicin, Irfan
Publicado 2023